Our expertise
Over the years, we have developed expertise over essential processes to serve the global consumers with highly innovative and effective products. This enables us to deliver exceptional quality and reliability as an innovator and manufacturer.
Generic Drug Development and Contract Research Services
We deliver high-quality and safe generic drugs to 49 countries across five continents, driven by the rapid generic drug development and reliable contract research services.
Well-defined process of R&D to Commercial Manufacturing
Cutting-edge research and development, systematic scaling up, contract manufacturing to optimize overall productivity, thorough clinical trials for additional safety evaluation, and solid commercial manufacturing, all in a well-defined step-by-step process.
Analytical method development and validation
Analytical method development and validation helps in getting accurate results and critical assessment of product-specific acceptance criteria.
ANDA Filing
We identify product potential, based on which we develop innovative process solutions. We then take care of the product approvals, finally ending with ANDA filing with the FDA.
IP Formulations and Process Technology
We have developed cost-effective yet highly efficient ways to develop IP oriented formulations. We also make the development of process technologies economical.
Experienced Regulatory Team &
Formulation Development
Our experienced regulatory teams conduct regular quality checks throughout the developmental process to ensure that our complicated generics are effective and safe. Robust API manufacturers back our Formulation Development, making sure our supply chain is reliable and unhindered in the long run.
Novel Drug Delivery Systems, Paragraph IV/ NCEs & 505(b)(2) Development
We have efficient development capability to produce Novel Drug Delivery Systems along with Paragraph IV, NCEs and 505(b)(2).
Manufacturing expertise at our technology equipped plants
Atlanta Plant
We manufacture oral solids in the form of tablets and capsules at our state-of-the-art plant in Atlanta, USA.
UNIT I : ORAL SOLIDS
| Dosage Forms | Annual |
|---|---|
| Tablets | 132.48 million |
| Capsules | 38.40 million |
Ahmedabad Plant
Our manufacturing plant at Ahmedabad, India is highly modern and advanced, with a massive production capability. We produce Small Vial Parenterals, Oral Solids & Liquids and Beta Lactum in millions annually, managed by an expert team.
UNIT II : GENERAL ORAL
| Dosage Forms | Annual |
|---|---|
| Tablets | 499.20 million |
| Capsules | 312 million |
| Dry Syrups | 12.48 million |
| Liquid | 12.48 million |
| ORS | 62.40 million |
UNIT III : SMALL VOLUME PARENTERALS
| Dosage Forms | Annual |
|---|---|
| Ampoules | 16.64 million |
| Liquid Vials | 16.64 million |
| Dry Powder Vials | 16.64 million |
| Lyophilized Vials | Under Installation |
UNIT IV : BETA LACTUM ORAL
| Dosage Forms | Annual |
|---|---|
| Tablets | 187.20 million |
| Capsules | 312 million |
| Dry Syrups | 12.48 million |
